Aldurazyme TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: laronidase
Pack: Aldurazyme 500 units/5 mL injection, 5 mL vial
Brand name
(ARTG)
: ALDURAZYME laronidase (rch) 500U/5mL injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Aldurazyme is indicated as long term enzyme replacement therapy in patients with Mucopolysaccharidosis (MPS I; alpha - L - iduronidase deficiency) to treat the non-neurological manifestations of the disease.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, concentrated
- Intravenous
- Colourless to pale yellow, clear to slightly opalescent solution that must be diluted prior to administration.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 5 mL vial pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient laronidase
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
